Introduction to Xeljanz (Tofacitinib) 1mg
Xeljanz (Tofacitinib) 1mg is a prescription medicine used to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It works by modulating the immune system to reduce inflammation and joint damage.
DIZUVA (Tofacitinib) 1mg is classified under Prescription Medicines, Immunology Medicines, Anti-Inflammatory Drugs, and Oral Immunomodulatory Therapies. It contains Tofacitinib, which inhibits Janus kinase (JAK) enzymes, helping to control abnormal immune responses.
Generic versions of DIZUVA 1mg are available in some markets containing the same active ingredient Tofacitinib, offering similar therapeutic benefits under medical supervision.
What Is Xeljanz (Tofacitinib) 1mg?
DIZUVA is the brand name for Tofacitinib, an oral immunomodulatory medication used to manage autoimmune diseases.
Tofacitinib belongs to a class of medicines called Janus kinase (JAK) inhibitors. These medicines regulate overactive immune system responses that cause inflammation and tissue damage.
Generic versions such as DIZUVA 1mg contain the same active compound and may be prescribed depending on availability and physician recommendation.
Drug Class and Mechanism of Action
Tofacitinib is classified as a Janus kinase (JAK) inhibitor with strong immunomodulatory properties.
How Tofacitinib Works
It works in several ways:
- Blocks JAK enzymes that activate inflammatory pathways
- Reduces immune system overactivity
- Helps decrease joint pain, swelling, and tissue damage
Through these mechanisms, Tofacitinib helps control autoimmune disease progression and symptoms.
How DIZUVA Works in the Body
In autoimmune diseases, the immune system attacks healthy tissues. DIZUVA regulates this response to reduce inflammation.
Key Actions of Tofacitinib
- Inhibits JAK signaling pathways
- Reduces immune-mediated inflammation
- Improves joint mobility and decreases pain
- Controls disease activity in ulcerative colitis and arthritis
Medical Uses of DIZUVA (Tofacitinib) 1mg
DIZUVA 1mg is widely prescribed for autoimmune disorders.
DIZUVA for Rheumatoid Arthritis
Helps reduce joint inflammation and prevent progressive joint damage.
Potential Benefits
- Reduced pain and swelling
- Improved physical function
- Slower progression of joint damage
DIZUVA for Psoriatic Arthritis
Used to manage joint symptoms and skin lesions associated with psoriatic arthritis.
DIZUVA for Ulcerative Colitis
Helps induce and maintain remission in moderate to severe ulcerative colitis.
Who Can Take DIZUVA 1mg?
This medicine should be used under the supervision of a qualified healthcare provider.
Eligibility Criteria
Patients may be prescribed DIZUVA if they:
- Have moderate to severe rheumatoid arthritis, psoriatic arthritis, or ulcerative colitis
- Can undergo regular blood monitoring
- Are evaluated for infection risks before starting therapy
Who Should Avoid DIZUVA (Tofacitinib) 1mg
DIZUVA should NOT be used by:
- Pregnant or breastfeeding women unless advised by a doctor
- Individuals with active infections
- Patients with known hypersensitivity to Tofacitinib
DIZUVA (Tofacitinib) 1mg Dosage and Administration
Standard Dosage Guidelines
Typical dosage recommendations include:
- DIZUVA 1mg twice daily (as prescribed)
- Can be taken with or without food
- Tablets should be swallowed whole
Dosage Adjustments
Doctors may adjust the dose depending on:
- Kidney or liver function
- Age and overall health
- Response to treatment and side effects
Side Effects of Xeljanz (Tofacitinib) 1mg
Common Side Effects
- Headache
- Upper respiratory tract infections
- Diarrhea or nausea
- Increased cholesterol levels
Serious Side Effects
- Risk of serious infections
- Blood clots
- Liver enzyme abnormalities
- Increased risk of certain cancers
Patients should report unusual symptoms to their doctor immediately.
Storage:
Store below 25°C in a cool, dry place, protected from sunlight and moisture. Keep out of reach of children.
Frequently Asked Questions (FAQs)
1. Can DIZUVA 1mg be taken long-term?
Yes, under medical supervision with regular blood tests to monitor safety.
2. Is DIZUVA safe during pregnancy?
No, Tofacitinib can cause harm to the fetus and must be avoided.
3. Can DIZUVA increase infection risk?
Yes, because it suppresses immune system activity.
4. Can DIZUVA be taken with food?
Yes, it can be taken with or without food.
5. Is DIZUVA 1mg the same as generic Tofacitinib?
Yes, it contains the same active ingredient Tofacitinib.
6. Do I need a prescription for DIZUVA 1mg?
Yes, it is a prescription-only medicine.
Medical Disclaimer
Disclaimer:
The information provided here is for educational purposes only and should not be considered medical advice. DIZUVA (Tofacitinib) is a prescription medicine and must be used under the supervision of a qualified healthcare professional.
